Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 40361 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 76744 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 99870 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 123210 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 453352 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 458231 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 521587 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 526793 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 553084 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 574529 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 603053 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 626363 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 656918 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 669442 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 687666 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 25800000 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 26600000 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 26800000 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 27400000 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 28400000 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 28900000 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 29200000 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 29300000 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 29500000 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31600000 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 31900000 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 32600000 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 32900000 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 34900000 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 35000000 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 35000000 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 35400000 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 37200000 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 9542 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 151045 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 172167 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 172912 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 173322 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 182351 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 182504 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 187850 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 187965 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 189096 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 190679 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | Peak area | Severe disease |